Table 2:
Genotypic
and Allele Frequency of MnSOD Single Nucleotide
Polymorphisms (SNPs) in control group and Type 2 Diabetes Mellitus patients
(T2DM). Chi-square test was used to determine significance at p < 0.05.
|
|
Control (n = 40) |
T2DM (n = 59) |
p-Value |
OR (95% CI) |
|
|
Rs480
Genotype |
|
|
<
0.001 |
4.068
(1.528-10.832)* |
|
|
CC (Ala) (n = 16) |
10
(62.5%) |
6
(37.5%) |
|||
|
CT (Ala/Val) (n = 55) |
26
(47.3%) |
29
(52.7%) |
|||
|
TT (Val) (n = 28) |
4
(14.3%) |
24
(85.7%) |
|||
|
Allele |
|
|
|||
|
f(C) |
57.50% |
34% |
|||
|
f(T) |
42.50% |
66% |
*Risk was calculated for a Val homozygote
carrier